The effects of depression, stress, and somatization on clinical prognosis and treatment in patients suspicious of benign prostatic hyperplasia
Main Article Content
Keywords
Depression, stress, somatoform disorder, lower urinary tract signs prostatic hyperplasia.
Abstract
Aim: It was the first research to study how depression, stress, and somatoform disorder affect therapy reply for lower urinary tract symptoms (LUTS), suspicious of benign prostatic hyperplasia (BPH). Method: Respondent Health Questionnaire-9,7- item Sweeping Nervousness Syndrome Scale, and PHQ 17 are being used to assess LUTS/BPH individuals. The main result was just the responder’s rate, which was defined as total IPSS score (6) at the conclusion of therapy. Results: The intensity of LUTS/BPH was considerably greater in people experiencing sadness (p value = 0.025; storage sub-sign (p value = 0.023) or else somatization (p value = 0.026) than in these deprived of, although standard of living remained higher for cases experiencing anxiousness (p value = 0.039) than that
of other deprived of. Nervous participants had a substantially larger number of non than those who were not (odds ratios [OR], 4.295, P = 0.023), whereas somatic respondents had the tendency to have greater non-responders (OR, 4.553, p value = 0.068). Our preliminary findings imply that sadness, anxiety, and somatic complaints might have had an impact on treatment manifestations of LUTS/BPH. Furthermore, apprehensive individuals with LUTS/BPH exhibited a worse response to therapy. Conclusion: Despite its drawbacks, the current study shows that doctors may also need to conduct a detailed examination of psychotic features in order to successfully manage individuals suffering LUTS/BPH.
References
interaction. Gastroenterology. 2019; 150(6): 1257- 1261.
2. Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M. Prevalence of Rome IV
functional bowel disorders among adults in the United States, Canada, and the United
Kingdom. Gastroenterology. 2020; 158(5): 1262- 1273.e1263.
3. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features
and Rome IV. Gastroenterology. 2019; 150(6): 1262- 1279.
4. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2019; 150(6): 1393- 1407.
5. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel
disorders. Gastroenterology. 2019; 130(5): 1480- 1491.